SH L 562BB

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SH L 562BB, covering 2011-08-03 to 2011-08-03. Get the full timeline:

Most recent: Clinical Trial Update: SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study [Phase 3]